While a higher-dose formulation of semaglutide (Wegovy) is specifically licensed for weight management, Ozempic should not be prescribed for weight loss alone
Additionally, the indication for which the individual was using a GLP-1RA (e.g., obesity, diabetes) cannot be determined from our data
Oka, J (April 2014)
Treatment adequacy is assessed with thyroid-stimulating hormone (TSH) testing, a standard biomarker [19,20,21,22]
Healthcare providers should assess for conditions that increase appetite, including uncontrolled diabetes (check HbA1c), thyroid disorders (TSH, free T4), and psychiatric conditions
The included trials also varied substantially in their populations, treatments and study designs, which may have affected the precision of the estimates